Acacia Subsidiary Enters into Settlement Agreement with AstraZeneca

By: Benzinga
Acacia Research Corporation (NASDAQ: ACTG ) announced today that its Accuhale LLC subsidiary has entered into a settlement agreement regarding pressurized metered dose inhalers with AstraZeneca LP (NYSE: AZN ),
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.